Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
The effect of IDH1 mutation on the structural connectome in malignant astrocytoma.
Greater lesion momentum between grades may cause more disconnection of core neurocircuitry.
»
06/09/16
Stomach cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
Current results indicate high fatality for stomach cancer, especially soon after diagnosis.
»
02/22/17
Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer.
Wip1 protein expression was positively correlated with p21 expression.
»
06/20/17
High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer
NLR is an independent prognostic factor.
»
12/21/17
Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes
Alterations in SIRT2-H3K18Ac suggest altered P300 activity.
»
12/20/17
miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer
miR-302b exhibited anti-tumor activity by reversing EphA2 regulation.
»
12/22/17
Diagnostic accuracy of
18
F–FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma
Whole-body PET/CT in addition to MRI of the head and neck improves detection.
»
12/22/17
Study of the tumor microenvironment during breast cancer progression
Expression of Th1 and Th17 genes was decreased in tumor tissues compared to control tissues.
»
12/22/17
Sarcosine influences apoptosis and growth of prostate cells via cell-type specific regulation of distinct sets of genes.
Sarcosine had pronounced stimulatory effects on clonogenicity.
»
06/14/17
ERBB2 mutation: A promising target in non-squamous cervical cancer.
Patients with ERBB2-mutated ICCs tended to have a worse prognosis.
»
11/03/17
< Prev
Next >